On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Immunobrain Ltd's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€500k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- TARGETBRAINPartner
Targeting Brain Inflammation For Improved Functional Recovery in Acute Neurodegenerative Disorders
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€500ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 1 shared project
- Weizmann Institute of ScienceIsrael · 1 shared project
- Lunds UniversitetSweden · 1 shared project
- Goeteborgs UniversitetSweden · 1 shared project
- Universitat ZurichSwitzerland · 1 shared project
- Universita Vita-Salute San RaffaeleItaly · 1 shared project
- St George'S Hospital Medical SchoolUnited Kingdom · 1 shared project
- GemacFrance · 1 shared project
- Proneuron Biothechnologies (Israel) LtdIsrael · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- immunology
- mortality
- stem cells
- stroke
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗